Showing papers in "European Urology in 2007"
••
TL;DR: NSS for small, easily resectable, incidentally discovered RCC in the presence of a normal contralateral kidney can be performed safely with slightly higher complication rates than after RN.
955 citations
••
TL;DR: A step-by-step approach to percutaneous nephrolithotomy and its complications and management is focused on, with the most important consideration for achieving consistently successful outcomes in PNL with minimal major complications being the correct selection of patients.
839 citations
••
TL;DR: This guideline is designed to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice.
506 citations
••
TL;DR: VIP with veil nerve sparing offers oncologic and continence results that are comparable to the results of conventional nerve-sparing radical prostatectomy, and early potency results are encouraging.
497 citations
••
TL;DR: PE is a highly prevalent sexual problem, with significant sexual and psychological comorbidities, and most men with PE do not seek assistance from their physician, and those who do are not satisfied with the results.
476 citations
••
TL;DR: The heating technique using magnetic nanoparticles was feasible and Hyperthermic to thermoablative temperatures were achieved in the prostates at 25% of the available magnetic field strength, indicating a significant potential for higher temperatures.
458 citations
••
TL;DR: Data strongly suggest that BPH is an immune inflammatory disease, and unravelling the specific nature of immune dysregulation may help design novel drugs with these specific targets in mind.
421 citations
••
TL;DR: In the REDUCE population, there is evidence of a relationship between the degree of LUTS and the level of chronic inflammation, and more severe inflammation was associated with higher IPSS scores.
379 citations
••
TL;DR: Reading of the literature on robot-assisted laparoscopic radical prostatectomy showed that RALP had a short learning curve and interesting postoperative results, especially with regard to continence recovery, whereas results on potency are based only on a limited number of patients and have to be considered as incomplete and premature.
361 citations
••
TL;DR: Extended and saturation biopsy schemes should be performed at first and repeat biopsy, respectively as a means of increasing accuracy of prostatic biopsy and reducing unnecessary prostate biopsy.
340 citations
••
TL;DR: HIFU for localized prostate cancer offered high control of local disease with low morbidity and the ability to repeat the HIFU treatment is of major interest.
••
TL;DR: Clinical outcomes after radical cystectomy are largely driven by pathologic stage, with patients with higher clinical stage more likely to be upstaged to non-organ-confined disease and at significantly higher risk than downstaged patients.
••
TL;DR: The TOT, a novel procedure for treatment of post-radical prostatectomy incontinence, was shown to be effective and well accepted by patients.
••
TL;DR: A direct positive relationship between the number of removed lymph nodes and long-term oncological outcome in patients with limited lymph node involvement or negative lymph nodes is indicated and ongoing prospective trials have to demonstrate a benefit in terms of biochemical-free and cancer-specific survival.
••
TL;DR: GC has a comparably acceptable toxicity profile compared with that of GP and seems active in patients with TCC, and no differences were noted in the overall toxicity profiles and any parameter of toxicity.
••
TL;DR: Obesity and increased stone density as detected by NCCT are significant predictors of failure to fragment renal stones by SWL, and an alternative treatment should be devised for obese patients with stone density>1000 HU.
••
TL;DR: Improvements in surgical technique and anaesthesia as well as increased quality of perioperative care in recent years have resulted in reduced morbidity and shorter hospital stay.
••
TL;DR: IL-8 appears to be the most reliable and predictive surrogate marker to diagnose prostate inflammatory conditions, such as CP/CPPS and BPH, as shown by recruitment of cells expressing cognate receptors in BPH prostate tissue.
••
TL;DR: In this preliminary report, the posterior reconstruction of the RS appears to be an easy and feasible technique even in a laparoscopic setting and time to continence recovery was significantly shortened.
••
TL;DR: The epidemiological data linking obesity and PCa with an emphasis on the clinical implications and how to improve outcomes among obese men is reviewed to suggest simple changes in clinical practice patterns can reduce the impact of nonbiological causes and may help improve PCa outcomes among obesity men.
••
TL;DR: The new clinical paradigm incorporates many of the consensed points of view discussed in traditional consensed algorithms exclusively designed for men with androgen insufficiency and represents one of the first attempts to address a logical management plan forMen with concomitant hormonal and sexual health concerns.
••
TL;DR: The treatment algorithm for managing patients with post-prostatectomy BCR was devised and PSA doubling time and prostatectomy Gleason score are the variables that best predict the development of distant metastasis and PCSM.
••
TL;DR: Because screening for PCa is frequently applied, the attention to this approach in this specific subgroup of men with PCa has increased, and there is a rising demand for an evidence-based approach, but unfortunately it is not yet available.
••
TL;DR: In this pilot study, the combination of alfuzosin 10 mg OD and sildenafil 25 mg OD is safe and more effective than monotherapy with either agent to improve both voiding and sexual dysfunction in men with LUTS suggestive of BPH.
••
TL;DR: PVP is characterized by excellent haemostatic properties and very low intraoperative complication rate even in patients on OA, and is recommended as first-line procedure for patients with symptomatic BPH at high risk of bleeding.
••
TL;DR: Both doses of fesoterodine were significantly better than placebo in improving the symptoms of OAB and produced a significantly greater Treatment Response versus placebo.
••
TL;DR: DSNB has matured into a reliable and safe method for assessing status of lymph nodes in cN0 penile carcinoma patients and has decreased since the procedure was modified, according to false-negative and complication rates.
••
TL;DR: The present study demonstrates a further increase in prostate growth in BPH patients with metabolic syndrome, and further studies are needed to confirm the results and to explain underlying mechanisms.
••
TL;DR: Measurements of DWT can detect BOO better than free uroflowmetry, postvoid residual urine, or prostate volume, and in clinical routine, DWT measurements can be used to judge BOO noninvasively.
••
TL;DR: After 2 and 3 yr of follow-up, HoLEP micturition outcomes compare favourably with TURP and late complications are equally low, suggesting HoLEp may be a real alternative to TURp.